Alvotech H1 FY26 adjusted EBITDA drops 12.7% to USD 46.9 million; revenue falls 30.8% to USD 211.9 million

Reuters2026/08/19 20:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Alvotech posted adjusted revenue of USD 211.9 million, down 30.8% from a year earlier.
Adjusted EBITDA fell 12.7% to USD 46.9 million; gross margin held at 54%, down 1 percentage point.
Product and service revenue slid 48.3% to USD 105.9 million; license and other revenue rose 4.4% to USD 105.7 million.
Cash balance ended at USD 142.8 million, down from Dec. 31, 2025; raised about USD 165 million in equity financing.
Resubmitted U.S. BLAs for AVT05 and AVT06; FDA decisions anticipated in Q4 2026, with full-year revenue seen at USD 650-700 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alvotech SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608191630PRIMZONEFULLFEED1001258420) on August 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Alvotech H1 FY26 adjusted EBITDA drops 12.7% to USD 46.9 million; revenue falls 30.8% to USD 211.9 million

You may also like

Crypto prices